Skip to content

NIRS Monitoring in the NICU and AKI

Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07222722
Enrollment
100
Registered
2025-10-30
Start date
2025-11-30
Completion date
2026-04-01
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury (AKI), Postnatal AKI

Brief summary

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Interventions

The renal NIRS device is a non-invasive tool that uses near-infrared light to measure oxygen saturation various tissues. Renal NIRS sensors will be placed by 24 hours of the participants' admission.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 30 Weeks
Healthy volunteers
Yes

Inclusion criteria

* Any neonate less than 30 weeks in gestational age * Willingness and capacity of both adult parents/guardians to sign consent

Exclusion criteria

* An infant with known congenital anomalies of the kidney (i.e., grade 4 or 5 vesicoureteral reflux (VUR), posterior urethral valves, moderate or severe hydronephrosis, autosomal recessive polycystic kidney disease (ARPKD), bilateral renal agenesis or dysplasia) * Age \>30 weeks gestational age * Age \<24 weeks and \<500 grams (will be excluded due to sensitivity of skin in this vulnerable population). * Clinician's decision that NIRS is not suitable due to the patient's clinical condition

Design outcomes

Primary

MeasureTime frameDescription
Average NIRS Value (SrSO2)Up to Day-of-life 7NIRS values measured as renal tissue oxygen saturation (SrSO2); measured continuously over first 7 days of life.

Secondary

MeasureTime frame
Serum Creatinine ValuesDay-of-life 1, Day-of-life 3, Day-of-life 7, Day-of-life 14
Average Urine OutputUp to Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations)
Length-of-Stay in NICUDay of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations)
Duration of Non-Invasive VentilationUp to Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations)
Duration of Mechanical VentilationUp to Day of NICU Discharge (Approximately Day-of-life 7; subject to large individual variations)

Countries

United States

Contacts

Primary ContactJordan Nelson, MD
Jordan.nelson@nyulangone.org3478223664

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026